# CT47A8

## Overview
CT47A8 is a gene that encodes the protein cancer/testis antigen family 47 member A8, which is part of a group of proteins known as cancer/testis antigens. These proteins are typically expressed in germ cells and certain cancerous tissues, but not in normal somatic cells, making them of particular interest in cancer research and immunotherapy. The CT47A8 protein is implicated in tumorigenesis due to its reactivation in various cancers, suggesting a potential role in cancer biology (Pertea2018CHESS:; Pertea2018Thousands). Additionally, CT47A8 has been associated with the severity of COVID-19, as it is located on the X chromosome and may contribute to the observed sex differences in disease severity (Gan2022Microbial). This dual involvement in cancer and infectious disease underscores the importance of CT47A8 as a subject of ongoing research for its potential as a biomarker and therapeutic target.

## Clinical Significance
CT47A8, a member of the cancer/testis antigen family, is primarily expressed in germ cells and certain tumors. Its expression is typically absent in normal somatic tissues, which makes it a potential target for cancer immunotherapy. Alterations in the expression of CT47A8 have been associated with tumorigenesis, as it is reactivated in some cancers, suggesting a role in cancer biology (Pertea2018CHESS:; Pertea2018Thousands).

In the context of COVID-19, CT47A8 has been identified as a gene located on the X chromosome that correlates with the severity of the disease. The expression of CT47A8, along with other genes on the X chromosome, may contribute to the sex bias observed in COVID-19 severity, with male patients often experiencing more severe symptoms. This suggests that CT47A8 could serve as a biomarker for predicting COVID-19 severity, potentially linked to immune response and inflammation (Gan2022Microbial).

The gene's involvement in both cancer and COVID-19 highlights its potential clinical significance, warranting further investigation into its role as a biomarker and therapeutic target in these conditions.


## References


[1. (Pertea2018CHESS:) Mihaela Pertea, Alaina Shumate, Geo Pertea, Ales Varabyou, Florian P. Breitwieser, Yu-Chi Chang, Anil K. Madugundu, Akhilesh Pandey, and Steven L. Salzberg. Chess: a new human gene catalog curated from thousands of large-scale rna sequencing experiments reveals extensive transcriptional noise. Genome Biology, November 2018. URL: http://dx.doi.org/10.1186/s13059-018-1590-2, doi:10.1186/s13059-018-1590-2. This article has 225 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13059-018-1590-2)

[2. (Gan2022Microbial) Hairun Gan, Jiumeng Min, Haoyu Long, Bing Li, Xinyan Hu, Zhongyi Zhu, Luting Li, Tiancheng Wang, Xiangyan He, Jianxun Cai, Yongyu Zhang, Jianan He, Luan Chen, Dashuai Wang, Jintao Su, Ni Zhao, Weile Huang, Jingjing Zhang, Ziqi Su, Hui Guo, Xiaojun Hu, Junjie Mao, Jinmin Ma, and Pengfei Pang. Microbial and human transcriptional profiling of coronavirus disease 2019 patients: potential predictors of disease severity. Frontiers in Microbiology, September 2022. URL: http://dx.doi.org/10.3389/fmicb.2022.959433, doi:10.3389/fmicb.2022.959433. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmicb.2022.959433)

3. (Pertea2018Thousands) Thousands of large-scale RNA sequencing experiments yield a comprehensive new human gene list and reveal extensive transcriptional noise. This article has 26 citations.